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Oligodendrocytes are cells that myelinate axons, providing saltatory conduction of action 
potentials and proper function of the central nervous system. Myelination begins prenatally in 
the human, and the sequence of oligodendrocyte development and the onset of myelination are 
not thoroughly investigated. This knowledge is important to better understand human diseases, 
such as periventricular leukomalacia, one of the leading causes of motor deﬁ  cit in premature 
babies, and demyelinating disorders such as multiple sclerosis (MS). In this review we discuss 
the spatial and temporal progression of oligodendrocyte lineage characterized by the expression 
of speciﬁ  c markers and transcription factors in the human fetal brain from the early embryonic 
period (5 gestational weeks, gw) until midgestation (24 gw). Our in vitro evidence indicated 
that a subpopulation of human oligodendrocytes may have dorsal origin, from cortical radial 
glia cells, in addition to their ventral telencephalic origin. Furthermore, we demonstrated that 
the regulation of myelination in the human fetal brain includes positive and negative regulators. 
Chemokines, such as CXCL1, abundant in proliferative zones during brain development and in 
regions of remyelination in adult, are discussed in the view of their potential roles in stimulating 
oligodendrocyte development. Other signals are inhibitory and may include, but are not limited 
to, polysialic acid modiﬁ  cation of the neural cell adhesion molecule on axons. Overall, important 
differences in temporal and spatial distribution and regulatory signals for oligodendrocyte 
differentiation exist between human and rodent brains. Those differences may underlie the 
unique susceptibility of humans to demyelinating diseases, such as MS.
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Furthermore, extensive studies have shown transcription factors 
essential for oligodendrocyte speciﬁ  cation as well as growth fac-
tors that inﬂ  uence oligodendrocyte proliferation and differentia-
tion (Lu et al., 2000, 2002; Orentas and Miller, 1996; Takebayashi 
et al., 2000). In the ventral diencephalon and telencephalon, Shh 
inﬂ  uences the expression of oligodendrocyte lineage genes, Olig1 
and Olig2, which are basic helix-loop-helix (bHLH) transcription 
factors (Lu et al., 2000; Pringle et al., 1996; Takebayashi et al., 2000; 
Tekki-Kessaris et al., 2001; Zhou et al., 2000). The question, how-
ever, remains to which extent could observations obtained on these 
animal models relate to human brain development.
In the recent years our laboratory has published several studies 
based on immunohistochemical analysis of the human fetal brain 
describing early oligodendrocyte speciﬁ  cation  (Filipovic et  al., 
2003; Jakovcevski and Zecevic, 2005a,b; Rakic and Zecevic, 2003a) 
and the onset of myelination (Jakovcevski et al., 2007). We have also 
pioneered the use of organotypic slice cultures, as well as primary 
cell cultures from human fetal brains, in addressing questions of the 
capacity of radial glia cells to generate oligodendrocytes (Mo and 
Zecevic, 2009), the interplay of other cell types and oligodendrocyte 
progenitor cells during brain development (Filipovic and Zecevic, 
2005, 2008), and axon-oligodendrocyte interactions preceding 
myelination (Jakovcevski et al., 2007). Here we will summarize 
INTRODUCTION
Oligodendrocytes are glia cells that produce myelin, the lipid-
enriched axon-ensheathing membrane, which is essential for 
saltatory conduction of action potentials in the central nervous 
system (CNS). They were ﬁ  rst discovered by Robertson (1899), 
but named and classiﬁ  ed by Rio Hortega (1921). The origin and 
differentiation of oligodendrocytes have been extensively studied 
in animal models, and are especially well documented in rodents, 
thanks to advances in various molecular biology techniques that 
have provided the means of genetic mapping of cell lineages in 
the developing mouse brain (He et al., 2001; Kessaris et al., 2006; 
Marshall and Goldman, 2002; Rivers et al., 2008; Tekki-Kessaris 
et al., 2001). Along the neural tube oligodendrocytes are produced 
ventrally under the inﬂ  uence of the morphogen Sonic Hedgehog 
(Shh), and migrate at the progenitor stage to dorsal regions (as 
reviewed in Miller, 1996; Richardson et al., 2000; Spassky et al., 
2000). It has been shown, however, that after the initial wave of 
ventrally derived oligodendrocytes, they are completely replaced 
by a dorsally derived population (Kessaris et al., 2006; Vallstedt 
et al., 2005). Progression of cells of oligodendrocyte lineage through 
various stages of differentiation has been described in depth in 
rodents using primary oligodendrocyte cell cultures (e.g. Miller, 
1996; Pfeiffer et al., 1993; Raff, 1989; Reynolds and Hardy, 1997). 
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results of those studies, compare them with other work published 
on developing human brain and put it all in the perspective of 
knowledge obtained from studies on animal models.
METHODOLOGICAL REMARKS
Several issues, ethical and methodological, need to be addressed 
regarding human fetal brain tissue. All of the tissue used in our 
studies was obtained after legal abortions performed either at the 
Obstetrics and Gynecology Clinic, University of Belgrade (Serbia), 
or from the Brain Bank, Albert Einstein College of Medicine (Bronx, 
NY). The Institutional Ethics Committees of these institutions and 
the University of Connecticut approved the tissue collection, and 
informed consent was obtained from the parents. The handling of 
tissue was performed in accordance with all regulations set forth by 
the Institutional Ethics Committees and the Helsinki Convention. 
No evidence of disease or developmental abnormalities was discov-
ered after ultrasonic and neuropathological examination of fetal 
brains. The ages of the embryos and fetuses were estimated on the 
basis of weeks after ovulation, crown-rump length (Olivier and 
Pineau, 1962), and anatomical landmarks (O’Rahilly et al., 1987).
Tissue was ﬁ  xed by submersion into 4% formaldehyde in 0.1 M 
phosphate buffer, typically within 15 min, but never longer than 
2 h post-mortem, which is among the shortest reported in the lit-
erature. Fixation times varied depending on the size of the tissue 
block, but were never shorter than overnight. Fixation was always 
done at 4°C, followed by cryoprotection in 30% sucrose solution 
in the same buffer, and freezing of tissue in isopentane cooled 
to −70°C. Despite very careful attempts made to standardize the 
conditions for each case, considerable differences in immunoreac-
tivity to certain antibodies could be detected. Each immunostain-
ing has to be evaluated by an experienced observer and antibody 
reactivity has to be assessed on case-to-case basis. Only cells that 
displayed typical morphology and distribution of the antigen as 
predicted (i.e.   transcription factors are nuclear, receptors are on 
the cell   membrane) were used in evaluation. Another source of 
difﬁ  culties in working with human tissue is that optimal antibody 
dilutions are difﬁ  cult to determine, since each individual sample 
may vary in reactivity to some antibodies. However, for most of 
the antibodies used in our studies we have been able to get fairly 
reproducible staining intensities. The antibodies and tissue samples 
that resulted in great variability in staining intensity and/or staining 
pattern were thus excluded from our analyses.
To be able to do experimental manipulation with human brain 
tissue, we have developed primary cell cultures and slice cultures 
from human fetal forebrains (Figure 1). These cultures are dif-
ferent from cultures taken from experimental animals in several 
respects. Firstly, human fetal cells are harvested from only one brain 
specimen at the time, unlike in animals where one whole, or even 
several litters can be pooled in order to obtain cells in optimal 
numbers. Additionally, the factors that greatly increase case-to-case 
variability of these cultures include genetic differences (humans are 
rarely “inbred”), age differences (age of the fetus is never completely 
precise within 1–2 weeks), and different conditions of tissue before 
cultures are made. In order to standardize to the maximum tissue 
quality as the only addressable problem among those mentioned 
above, we have devised a protocol to keep tissue in oxygenated 
buffered saline solution supplemented with glucose and glutamine 
on ice during transport. Transportation time is typically <2 h. In 
this way after preparation of cultures usually less then 10% of cells 
are dead as assessed by trypan-blue staining (Mo et al., 2007).
In addition to long-term cell cultures (min. and max. time, 12 h 
to 5 days), which we used to study radial glia cells (Mo and Zecevic, 
2008, 2009; Mo et al., 2007), and oligodendrocytes (Filipovic and 
Zecevic, 2005, 2008), we also established acute cell cultures (Howard 
et al., 2006; Jakovcevski and Zecevic, 2005b). Acute cultures are dis-
sociated cells from well-deﬁ  ned brain regions, maintained for 4–6 h 
FIGURE 1 | Cell death in chronic slice cultures. (A) The representative image 
of activated caspase-3 staining (red, arrows) on the ventricular/subventricular 
zone (VZ/SVZ) of the slice culture from a 19-week-old human fetus after 5 days 
in vitro. Nuclei are counterstained with bisbenzamide (blue). Scale bar: 20 µm. 
(B) Proportion of caspase-3a+ cells in all bisbenzamide-labeled nuclei in the VZ/
SVZ and intermediate zone/cortical plate (IZ/CP) of 19-week-old human fetus. 
Note the higher percentage of apoptotic cells in the VZ/SVZ, similar to results 
obtained by TUNEL staining on frozen sections (Rakic and Zecevic, 2000).Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  5 | 3
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before ﬁ  xation and immunostaining. They were used to estimate 
the proportions of marker-deﬁ  ned cell populations among all cells 
in the region (Figures 6C,D).
In order to manipulate experimental conditions, but still preserve 
cell-to-cell interactions and extracellular matrix composition present 
in vivo, we have established organotypic slice culture from the human 
fetal forebrains. Brain slices were kept for 3–5 days in vitro. Under cul-
ture conditions cells in slices retained viability after 5 days with very 
little cell death as shown by activated   caspase-3 staining (Figure 1). 
In addition, both cell proliferation and normal cellular composition, 
judged by the staining patterns with the cell-type speciﬁ  c antibod-
ies, closely resembles in vivo sections from the same age. However, 
there are a few exceptions to this, most notably the oligodendrocyte 
maturation seems to be accelerated in slices, as discussed below 
(Jakovcevski and Zecevic, 2005a; Jakovcevski et al., 2007).
SEQUENTIAL EXPRESSION OF IMMUNOHISTOCHEMICAL 
MARKERS DURING PROGRESSION OF OLIGODENDROCYTE 
LINEAGE IN HUMANS
Oligodendrocyte lineage has been described in detail in rodents by 
expression of speciﬁ  c proteins used as immunomarkers of various 
stages in oligodendrocyte development (e.g., Pfeiffer et al., 1993). 
Oligodendrocytes are also the cell population in the central nervous 
system with the most signiﬁ  cant turnover, and as such, all stages of 
precursor cells exist in the CNS throughout adult life (Dawson et al., 
2003). Oligodendrocyte development in humans begins during the 
second trimester of gestation and progresses towards birth, and fur-
ther into adulthood (Back et al., 2001; Jakovcevski and Zecevic, 2005a; 
Rakic and Zecevic, 2003a; Rivkin et al., 1995; Yakovlev and Lecourse, 
1967). We focused recently on elucidating progression of oligodendro-
cyte lineage in humans in the ﬁ  rst half of gestation (Figure 2).
Early oligodendrocyte progenitor cells are characterized by 
their expression of platelet derived growth factor receptor alpha 
(PDGFRα) and NG2 proteoglycans (Pringle and Richardson, 1993; 
Pringle et al., 1992; Stallcup and Beasley, 1987) and typical mor-
phology with few ramiﬁ  ed processes (Figure 3A; also Figures 4 
and 5; for more elaborate description see Jakovcevski and Zecevic, 
2005a; Figure 2). These cells are still mitotic, so we consider them 
“progenitors”. Later along the oligodendrocyte lineage cells are not 
considered to be proliferative any more, thus in this review we use 
the term “precursors” for these cell types. We detected the ﬁ  rst 
PDGFRα expressing (PDGFRα+) cells in the forebrain of 10 gw 
old fetus, but they appear in higher numbers only around 15 gw, 
when they are most numerous in the ganglionic eminences and 
in the cortical VZ/SVZ (Figure 4). By midgestation (19–22 gw) 
oligodendrocyte precursor cells invade more dorsal areas of the 
telencephalic wall, including the cortical plate. During the whole 
period of our observation (from the onset of neurogenesis, at 5 gw, 
until the beginning of the third trimester, 24 gw) early oligodendro-
cyte progenitors were most dense in the cortical subventricular 
FIGURE 2 | Time-course of various oligodendrocyte lineage markers 
expression in the human forebrain. (A) Early oligodendrocyte precursor cells 
appear around 9 gw in the ganglionic eminence, and during the next few weeks 
spread to cortex. Late oligodendrocyte precursors appear in modest numbers 
around 15 gw. MBP+ cells with typical oligodendrocyte morphology are very 
sparse at midgestation, but their population steadily enlarges. The ﬁ  rst myelin 
sheaths can be demonstrated by MBP staining at 18 gw in thalamus, and 
around 21 gw in the internal capsule. During the whole period of our observation 
(up to 24 gw) cortical white matter was not myelinated, i.e. not “white” . (B–E) 
Examples of 3D reconstructions from serial confocal sections stained with anti-
PDGFRα (B), anti-NG2 (C), anti-O4 (D) and anti-MBP (E) monoclonal antibodies. 
Image on panel B was taken from ganglionic eminence subventricular zone at 
15 gw, panels (C) and (D) from cortical subplate zone at 22 gw and panel (E) 
from internal capsule, 24 gw. Scale bar: 20 µm.Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  5 | 4
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FIGURE 3 | Cells of oligodendrocyte lineage in culture. (A) Early 
oligodendrocyte precursors expressing PDGFRα. (B) O4+ late oligodendrocyte 
precursors (green), some of them double-labeled with NG2 (yellow in overlay) 
and some early oligodendrocyte precursors labeled only with NG2 (red). 
(C) GFAP+ astrocyte (green) among MBP+ oligodendrocytes (red). (D) All cultured 
oligodendrocytes express nuclear Olig2 (red), here shown in the MBP+ mature 
oligodendrocytes (green). (E, F) Confocal image of an oligodendrocyte with 
Olig2+ nucleus that produces MBP+ myelin-like membrane (green). Interestingly, 
Olig2 expression is not localized only to the cell nucleus, but it is also seen in the 
cytoplasm. Scale bar: (A–D) 20 µm, (E, F) 10 µm.
zone, consistent with their origin from this secondary prolifera-
tive zone in the human cortex (Jakovcevski and Zecevic, 2005a; 
Figures 4 and 6).
In the next stage in oligodendrocyte development, late oli-
godendrocyte precursor cells are characterized by O4 immunoreac-
tivity, whereas pre-myelinating oligodendrocytes are reactive to O1 
antibody (Figures 2D and 3B). O4 and O1 antibodies were raised 
against glycoproteins in the oligodendrocyte membrane and are 
shown to speciﬁ  cally label cultured late oligodendrocyte precursor 
cells (Bansal et al., 1989; Sommer and Schachner, 1981; Warrington 
and Pfeiffer, 1992). Staining of tissue sections with these antibodies 
is often hampered by the instability of the glycan epitopes to ﬁ  xa-
tion. Earlier study on rat brain sections has shown that, indeed, it 
is not ﬁ  xation but freezing that disperses the antigens and hampers 
immunostainings (Warrington and Pfeiffer, 1992). In our studies, 
however, we have been able to detect O4 and O1 expressing cells 
in human brains when we omitted detergent from the blocking 
solution. Similar results were reported by Back et al. (2001). In the 
human forebrain at midgestation (20–22 gw), we reported that O4+ 
and O1+ cells are especially dense in the subplate layer, immediately 
bellow the cortical plate (Jakovcevski and Zecevic, 2005a; Rakic and 
Zecevic, 2003a). This distribution of late oligodendrocyte precur-
sors raises a possibility that transient subplate layer is important 
for maturation of oligodendrocytes. This is not inconceivable, since 
subplate is the target of numerous afferent ﬁ  bers (Kostovic and 
Judas, 2002; Kostovic and Rakic, 1990) and has a rich extracellular 
matrix (Sheppard et al., 1991), also attracting numerous glial ﬁ  bril-
lary acidic protein expressing astrocytes at midgestation (Zecevic, 
2004). Considering the importance of transient subplate layer 
which receives the thalamic afferents essential for proper wiring 
of cortical neurons (McKellar and Shatz, 2008; Moore et al., 2008), it 
is tempting to speculate that oligodendrocytes come to the subplate 
to obtain yet unknown signals necessary for their maturation and 
myelination of the axons in correct sequence.
Maturation of oligodendrocytes is marked by the expression 
of myelin proteins, and the two major myelin proteins, myelin 
basic protein (MBP) and proteolipid protein (PLP), are the ﬁ  rst 
to be expressed at detectable levels (Verity and Campagnoni, 
1988). MBP was detected very early in human embryonic brains 
(around 5 gw), but this expression was attributed to Golli/MBP 
splice variants (Tosic et al., 2002; Zecevic et al., 1998). In the 
forebrain, ﬁ  rst MBP+ cells of typical oligodendrocyte morphol-
ogy (Figures 3C–F) were found at 18 gw, around the middle 
of intrauterine development (Back et al., 2001; Jakovcevski and 
Zecevic, 2005a). MBP+ cells are scattered through the intermedi-
ate zone, the future white matter, and increase in numbers with 
progression of development (Figure 2E; Jakovcevski and Zecevic, 
2005a). Our evidence supports the ventral to dorsal progres-
sion of oligodendrogenesis, also reported in rodents (Pringle and 
Richardson, 1993; Timsit et al., 1995). Indeed, a ventro-dorsal Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  5 | 5
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gradient in the extent of myelination (Jakovcevski et al., 2007) 
and in oligodendrocyte precursor cells density (Jakovcevski 
and Zecevic, 2005a,b; Rakic and Zecevic, 2003a) was seen in the 
human fetal forebrain.
Finally, in the rodent forebrain oligodendrocytes are initially 
derived from ventrally positioned ganglionic eminences (GE), 
whereas later they originate from the dorsal cortical subventricu-
lar zone (Kessaris et al., 2006; Marshall and Goldman, 2002). In 
human fetal forebrains at midgestation a subpopulation of cor-
tical oligodendrocyte progenitor cells was expressing Dlx2 and 
Nkx2.1 (Rakic and Zecevic, 2003a), transcription factors speciﬁ  c 
for ventrally derived cells in rodents (Anderson et al., 1997; He et al., 
2001; Marin and Rubenstein, 2001). However, as these transcrip-
tion factors show a strong signal in the human proliferative zones 
of both GE and cortex (Rakic and Zecevic, 2003b), the origin of 
human Dlx2- and Nkx2.1-expressing oligodendrocyte progenitor 
cells could not be simply determined. Another large population of 
oligodendrocyte progenitor cells at this stage did not express Dlx2 
and Nkx2.1 transcription factors, and could represent population 
of dorsally derived oligodendrocytes in the human brain (Figure 5; 
Rakic and Zecevic, 2003a). Yet a third population of cells co-labeled 
with oligodendrocyte progenitor markers (PDGFRα, NG2, Olig1), 
FIGURE 4 | Early oligodendrocyte progenitors in 15-week-old human 
forebrain. (A, B) Representative image of PDGFRα+ early oligodendrocyte 
progenitors (green, arrows) in ganglionic eminence subventricular zone (GE SVZ, 
(A)) and cortical SVZ (Cx SVZ, (B)). Nuclei are counterstained with bisbenzamide 
(bb, blue). (C) Proportion of PDGFRα+ cells from all cells in these two regions at 
15 gestation weeks. bv, blood vessel.
FIGURE 5 | The expression of Dlx2 and PDGFRα in 15 weeks old human fetal brain. Dlx2 (red) and PDGFRα (green, arrows) are usually not co-expressed in the 
emerging cortical white matter (A) and ganglionic eminence (B). Scale bar: 100 µm (A), 20 µm (B).Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  5 | 6
Jakovcevski et al.  Human oligodendrocyte development and myelination
stem cell marker nestin, and markers of cells from hematopoietic 
lineage (CD34, CD68) was present in what appears to be a stream 
of cells migrating between the ganglionic eminences and cortical 
subventricular zone (Rakic and Zecevic, 2003a). These combined 
ﬁ  ndings suggest multiple origins of human cortical oligodendro-
cytes (Jakovcevski and Zecevic, 2005a,b; Rakic and Zecevic, 2003a) 
and have broad implications for normal brain development as well 
as white matter pathologies.
It is possible that oligodendrocytes derived from various sources 
have different roles, or myelinate different axonal pathways. This 
becomes especially important and demands further investigation in 
the light of reports that implicate oligodendrocytes in other func-
tions in addition to “traditional” myelin formation, including syn-
aptic regulation and signaling at the nodes of Ranvier (Bergles et al., 
2000; Butt et al., 1999; Lin et al., 2005; Nishiyama et al., 2009).
OLIG GENES AND THE COMMON OLIGODENDROCYTE – 
NEURONAL PROGENITOR CELL
Studies of origin of oligodendrocytes in rodents have shown that 
ventral morphogen Shh is essential for early speciﬁ  cation of oli-
godendrocyte progenitors in the neural tube (Nery et al., 2001; 
Tekki-Kessaris et al., 2001). Shh activates a cascade of transcrip-
tion factors including Pax10, Dlx2, Nkx2, Olig1 and Olig2 (Nery 
et al., 2001; Pringle et al., 1996; Tekki-Kessaris et al., 2001). Olig2 
was described in neural progenitors that give rise to both motor 
neurons and oligodendrocytes in the ventral spinal cord region 
(Lu et al., 2000, 2002; Takebayashi et al., 2000; Zhou et al., 2000). 
Olig genes belong to a bHLH group of transcription factors that 
are necessary and sufﬁ  cient for generation of oligodendrocytes and 
for myelination in mice (Lu et al., 2000, 2002; Takebayashi et al., 
2002; Tekki-Kessaris et al., 2001; Zhou and Anderson, 2002; Zhou 
et al., 2000; 2001). In the human fetal brain we demonstrated the 
expression of Olig2 in the ganglionic eminences and the medial 
cerebral cortex starting as early as 5 gw, before the onset of either 
neurogenesis or oligodendrogenesis (Figures 6A,B; Jakovcevski 
and Zecevic, 2005b). Our study also revealed that various cell 
types later in development express both Olig1 and Olig2. Most 
notably, Olig2 is expressed in all MBP+ cells in the human fetal 
forebrain and spinal cord at midgestation, and in around 50% of 
early oligodendrocyte progenitors in the SVZ. At the same time 
and at the same location, cortical SVZ, a subpopulation of MAP2+ 
neuronal progenitors is also Olig2+. In contrast, mature neurons in 
the cortical plate labelled with either NeuN or GABA antibodies, 
do not co-express Olig2 (Jakovcevski and Zecevic, 2005b). Taken 
together these observations suggest existence of a common progeni-
tor cell for oligodendrocytes and at least some neuronal classes in 
the human forebrain. Similar relationship was extensively reported 
in rodent spinal cord where oligodendrocytes and motoneurons 
FIGURE 6 | (A, B) Olig2 expression in human embryonic (5 gw) forebrain. (A) Olig2 cells (red) in the primordial plexiform layer (ppl), but not in the 
ventricular zone (VZ), where vimentin+ radial glia cells (green) are dividing. (B) Olig2 is expressed in nuclei of MAP2+ young neurons (green) at this stage. (C, D) 
Densities of Olig2+ cells (red) in the acute (4 h in vitro) dissociated cell cultures from human cortical (Cx) and ganglionic eminence (GE) ventricular/
subventricular zones at midgestation (20 gw). Nuclei are counterstained by bisbenzamide (blue). Detailed quantiﬁ  cation was published by Jakovcevski and 
Zecevic (2005b).Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  5 | 7
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develop from the same Olig2 expressing domain, as seen by various 
methods including Olig2-deﬁ  cient mice (reviewed in Lu et al., 2002; 
Richardson et al., 2000; Rowitch, 2004). In the forebrain, however, 
the situation appears to be more complex. Common progenitor cell 
has been suggested for cortical interneurons and oligodendrocytes 
derived from ganglionic eminences (He et al., 2001), and a recent 
fate-mapping study shows that oligodendrocyte precursors in adult 
mice give rise to projection neurons in the piriform cortex (Rivers 
et al., 2008). On the basis of our studies of olig transcription factors’ 
expression in the fetal human central nervous system, we propose 
the model linking oligodendrocyte and neuronal lineages in brain 
and spinal cord through common Olig2-expressing progenitors 
(Figure 7).
Genetic mapping and heterologous transplantation fate map-
ping studies in mice have shown that Olig2 domain within medial 
ganglionic eminence gives rise to cortical interneurons (Butt et al., 
2005; Miyoshi et al., 2007). There is, however a controversy about 
the necessity of Olig2 for cortical interneuron fate determination. 
When Olig2 was ablated from cortical progenitors no change in 
interneuronal populations was observed (Miyoshi et al., 2007). One 
possible explanation for this ﬁ  nding could be that other bHLH 
genes, like Olig1, compensate for it. In our study we found Olig1 co-
localized in vimentin-expressing cortical radial glia cells, a cell type 
demonstrated to be a multiple neural progenitor (Mo and Zecevic, 
2009; Mo et al., 2007). We have no evidence that in human brain 
Olig1 is co-expressed in neuronal populations, but that does not 
preclude the possibility that by the time neurons acquire their fate 
this gene gets down-regulated (Jakovcevski and Zecevic, 2005b). 
This inability to draw conclusions about temporal developmental 
events is an intrinsic limitation of all studies on ﬁ  xed human tis-
sue, and is the most important reason why we resorted to different 
in vitro systems.
In vitro, Olig2 plays a role in self-renewal of mouse neurosphere 
cultures, and in differentiation of neurons and oligodendrocytes in 
FIGURE 7 | Schematic representation of possible lineage relationships 
between neurons and oligodendrocytes linked via Olig transcription 
factors in human CNS development, based on our results (Jakovcevski 
and Zecevic, 2005b). (A) In the embryonic forebrain Olig1 and Olig2 appear to 
be expressed by separate progenitor cell pools, and our evidence suggests that 
Olig2+ progenitors give rise to neurons. Later during fetal development early 
oligodendrocyte progenitors express both Olig1 and Olig2, but mature MBP+ 
oligodendrocytes in the fetal forebrain are Olig1−/Olig2+. (B) In the embryonic 
human spinal cord we detected only Olig2 expression. At the later age (15 gw) 
Olig1 is expressed in early oligodendrocyte progenitors, whereas Olig2 is 
expressed in MBP+ oligodendrocytes. Interestingly, Olig2 was expressed in 
many NeuN+ postmitotic neurons in the dorsal, but not ventral horn.Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  5 | 8
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appropriate condition media (Hack et al., 2004). In cultures with 
growth factors (FGF2 and EGF), Olig2 was expressed in almost all 
progenitors derived from mouse ganglionic eminences or cortex, 
whereas dorsal transcription factors, Pax6 and Emx1, were down-
regulated (Hack et al., 2004). In contrast, in cryosections of human 
lateral ganglionic eminence at 15–20 gw, Olig2 and Pax6 were co-
expressed in the same progenitor cells. This ﬁ  nding was extended 
to cell cultures from cortical VZ/SVZ. Co-expression of these two 
transcription factors in dividing progenitor cells is consistent with 
an increased complexity of human neural progenitor cells in com-
parison to other mammals (Mo and Zecevic, 2008).
RADIAL GLIA DERIVED SUBPOPULATION OF FOREBRAIN 
OLIGODENDROCYTES
As has been discussed above, we reported that in the VZ/SVZ of the 
fetal forebrain, cells occasionally co-express radial glia cells markers 
and oligodendrocyte lineage markers, suggesting lineage relationship 
(Jakovcevski and Zecevic, 2005a,b). Radial glia are multipotent pro-
genitor cells in rodents, generating projection neurons (Miyata et al., 
2001, 2004; Noctor et al., 2001) and a subpopulation of forebrain oli-
godendrocytes (Casper and McCarthy, 2006; Malatesta, et al., 2003). 
Similar to these ﬁ  ndings, radial glia cells are also neuronal and oli-
godendrocyte progenitor cells in human fetal brain (Mo and Zecevic, 
2009; Mo et al., 2007). In vivo loss- and gain-of-function studies that 
are successfully used in animal models to show linage relationship 
are not possible in humans. To study cortical neural progenitors and 
their progeny, we established an in vitro system with human fetal 
brain tissue. This approach enabled us to use some of experimental 
methods not commonly applied to human brain. For example, the 
Cre/loxP co-transfection was used to study the relationship of two 
cell types: radial glia and oligodendrocytes. We ﬁ  rst isolated human 
fetal radial glia in culture and then transfected them with a BLBP-
Cre/Floxed-YFP to study cell fate of their progeny. Thus, speciﬁ  city 
of BLBP (brain lipid binding protein) plasmid to radial glia cells was 
combined with YFP (yellow ﬂ  uorescent protein) reporter signaling 
related to β-actin-like promoter that remains active in cells after dif-
ferentiation. The Cre/loxP method made it possible to see the progeny 
of BLBP+ radial glia even after BLBP expression was downregulated 
during cell differentiation to another cell type (Mo and Zecevic, 
2009; Mo et al., 2007). As we expected from the initial ﬁ  ndings of 
double-labeled cells in cryosections of fetal forebrain, in vitro results 
directly demonstrated that a small subset of fetal radial glia cells dif-
ferentiates along oligodendrocyte linage following the same path as 
described in vivo (Jakovcevski and Zecevic, 2005a). Transfected cells 
expressed ﬁ  rst NG2 and O4 (Figure 8), and subsequently markers 
and morphology of premyelinating oligodendrocytes labeled with 
MBP and MOG (myelin oligodendrocyte glycoprotein) (Figure 5 in 
Mo and Zecevic, 2009).
We further demonstrated that this in vitro generation of oli-
godendrocyte progenitors from isolated radial glia cells was under 
Shh inﬂ  uence. This is not surprising considering a well-described 
role of this morphogen in brain development in rodents (Nery et al., 
2001; Tekki-Kessaris et al., 2001). However the role of Shh in normal 
human forebrain development, and speciﬁ  cally in dorsal oligoden-
drogenesis, is less well documented. From this aspect, our ﬁ  nding 
that radial glia enriched from cortical VZ/SVZ of midgestational 
(20 gw) fetuses expressed both Shh receptors, Ptc1 (patched) and 
Smo (smoothened), was consistent with the idea that Shh inﬂ  uences 
human forebrain development in a similar way that was reported 
in rodents. We found that adding Shh in culture of radial glia cells, 
increased the number of generated O4+ oligodendrocyte precursor 
cells, whereas adding Shh inhibitor, cyclopamine reduced the number 
of O4+ cells in these cultures. Taken together these ﬁ  ndings support 
the idea that Shh usually thought of as a ventral morphogen, also may 
play a role in dorsal oligodendrogenesis in human forebrain.
Dorsal transcription factor Pax6 has been reported to be impor-
tant for generation of neurons in rodents (Götz et al., 1998; Heins 
et al., 2002), and also in humans (Mo and Zecevic, 2008). Pax6 how-
ever may also have a role in oligodendrogenesis (Mo and Zecevic, 
2008). Other transcription factors, such as Olig1 and Olig2 may be 
necessary to specify radial glia as oligodendrocyte progenitors. Indeed 
we have observed that Olig1 and Olig2 can be co-expressed with 
radial glia marker vimentin along the ventricular zone at 15 gw (Mo 
and Zecevic, 2009). It would be important to determine whether a 
majority or only a speciﬁ  c subtype of human oligodendrocytes is gen-
erated from radial glia cells and whether radial glia are the only early 
oligodendrocyte progenitors in the cortical VZ/SVZ. Alternatively 
radial glia cells could generate oligodendrocytes only at a speciﬁ  c 
developmental stage or at a particular brain region, such as cortical 
VZ/SVZ. However, without careful quantiﬁ  cation on a larger sample 
size, we do not know how widespread these phenomena are. Equally 
unknown is how they change during the span of development? This 
is particularly important to establish, since developmental potential 
of progenitor cells becomes more and more restricted over time.
ASTROCYTE-OLIGODENDROCYTE INTERACTIONS DURING 
OLIGODENDROCYTE DEVELOPMENT
Formation of myelin during primary myelination and its restora-
tion in remyelination, involves proliferation, migration and dif-
ferentiation of oligodendrocyte progenitors into myelin-  forming 
oligodendrocytes. Growth factors, cytokine members of the 
interleukin (IL) superfamily, chemokines, such as growth-related 
oncogene alpha (GRO-α) also referred to as CXCL1, and other 
FIGURE 8 | Human fetal radial glia cell in culture differentiates as an 
oligodendrocyte progenitor. BLBP-Cre/Floxed-YFP transfected cell (green) 
co-labeled with O4 (red) after 7 days in culture. Scale bar: 20 µm.Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  5 | 9
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index   indicates more advanced differentiation of oligodendrocyte 
progenitors (Sakurai et al., 1998). In the ﬁ  rst 48 h in vitro, CXCL1 
treated slices had lower differentiation index than the control ones 
(0.17 ± 0.02 vs. 0.24 ± 0.03, n = 3, P < 5), while at 5 days the dif-
ferentiation index was signiﬁ  cantly higher in treated slices than in 
the controls (0.6 ± 0.07 vs. 0.4 ± 0.05, P < 0.05). Moreover, at 5 days 
in vitro MBP+ oligodendrocytes in treated slices had longer and 
more branched processes as compared to controls (Figures 9D,E). 
Western blots revealed increased levels of MBP after CXCL1 treat-
ment, as compared to controls (Figure 9I). In contrast, in the pres-
ence of either the CXCR2 antagonist (100 nM, 24 h) or after blocking 
ERK1/2 activation with PD98059 (50 µM, 24 h), the number of 
MBP+ oligodendrocytes was signiﬁ  cantly decreased (Figure 9B). 
Taken together these results conﬁ  rmed the role of CXCL1 not only 
in proliferation, but also in oligodendrocyte differentiation.
To test if this positive effect was due to secreted factors from dif-
ferent cell types, we isolated the effect of microglia and astrocytes 
by selectively eliminating each cell type with appropriate toxins 
(Filipovic and Zecevic, 2008). We collected conditioned media from 
these cell type speciﬁ  c cultures, and treated slices with either astro-
cyte or microglia conditioned media for 24 h. Four days later the 
number of MBP+ oligodendrocytes was quantiﬁ  ed. Only the con-
ditioned medium from CXCL1 treated astrocytes (CXCL1–ACM) 
increased the number of MBP+ oligodendrocytes, as compared to 
control media. In contrast, the number of MBP+ oligodendocytes sig-
niﬁ  cantly declined when ERK1/2 or IL-6 were blocked (Figure 9C). 
In addition, blocking of either CXCR2, ERK1/2 activation or IL-6 
release from astrocytes, changed the morphology of MBP+ cells, 
which exhibited less elaborate processes (Figures 9F–H).
This ﬁ   nding supported our hypothesis that the CXCL1/
ERK1/2/IL-6 pathway had an important role in oligodendrocyte 
progenitor proliferation and their subsequent differentiation into 
premyelinating oligodendrocytes. In the absence of microglia or 
astrocytes, MBP+ oligodendrocytes had less branched processes 
and their number was reduced as well. Similar to ﬁ  ndings on pro-
liferation, the differentiation of oligodendrocyte progenitors was 
decreased by neutralization of IL-6, but not of CXCL1 secreted 
from astrocytes (Figure 9C). We propose that a novel interaction 
between astrocytes and oligodendrocytes, the one that includes 
CXCL1/IL-6 signaling pathway, enhances development of human 
fetal oligodendrocytes.
During remyelination in MS, basic processes of oligodendrocyte 
development including proliferation, migration and differentiation 
of oligodendrocytes progenitors are recapitulated. For that reason 
it is of extreme importance to understand processes during normal 
oligodendrogenesis. We describe here that constitutive expression 
of CXCL1 has physiological relevance, whereas exogenous CXCL1 
might be relevant in pathological conditions, such as developmental 
disorders of white matter, or in MS. This is supported by the ﬁ  nd-
ing that CXCL1 is abundant around MS lesions (Filipovic et al. 
2002, 2003), the site where attempts of remyelination are found 
(Chang et al., 2002; Franklin, 2002; Levine et al., 2001; Raine et al., 
1981;Wolswijk, 1998). We discovered that CXCL1 acts in synergy 
with IL-6. The function of IL-6 is not well understood, but it was 
reported to range from protracting relapses (Diab et al., 1997) to 
limiting demyelination in EAE (Di Marco et al., 2001; Willenborg 
et al., 1995). Future studies should address the role of this  pathway 
mediators inﬂ  uence oligodendrocyte progenitor cells proliferation 
and/or differentiation, and are also very important for remyelina-
tion (e.g. Dubois-Dalcq and Murray, 2000; Gard and Pfeiffer, 1993; 
Grinspan, 2002; Mason et al., 2003; Ransohoff et al., 2002; Wilson 
et al., 2003). Moreover, it has been demonstrated that this chemok-
ine is upregulated during experimental autoimmune encephalomy-
elitis (EAE) (Glabinski et al., 2000) and around lesions in multiple 
sclerosis (Filipovic et al., 2002, 2003; Omari et al., 2005, 2006). We 
studied the distribution of chemokine CXCL1 and its receptor 
CXCR2 in human developing forebrain, and reported that it is 
highly expressed in cortical VZ/SVZ (Filipovic et al., 2003) in accord 
with an earlier study in rodents (Robinson and Franic, 2001). The 
SVZ is one of the largest proliferative regions with multiple pro-
genitor classes in developing rodent (Lachapelle et al., 2002; Luskin, 
1993) and human brain (Rakic and Zecevic, 2003a,b; Sanai et al., 
2004; Zecevic et al., 2005). The SVZ in adult brain is also a source 
of newly generated oligodendrocytes in MS (Nait-Oumesmar et al., 
2007). In rats, CXCL1 induces proliferation of oligodendrocyte 
progenitors and limits their migration (Robinson et al., 1998). The 
fact that human and rodent oligodendrocyte progenitors differ-
ently respond to various mitogens (Armstrong et al., 1992; Scolding 
et al., 1995; Wilson et al., 2003; Zhang et al., 2000) led us to explore 
the role of CXCL1 in the human fetal forebrain. Moreover, we 
were intrigued by the ﬁ  nding that during midgestation very few 
oligodendrocyte progenitors express CXCR2 receptor (Filipovic 
et al., 2003). Our data suggested that if this chemokine has a role 
in proliferation of oligodendrocyte progenitor cells, it may exert its 
action trough other cell types present in the brain. To study cell-
to-cell interactions we used organotypic slice cultures from cortical 
VZ/SVZ zones and demonstrated that proliferation of human fetal 
oligodendrocyte progenitor cells is indeed dependent on CXCL1/
CXCR2 signaling (Filipovic and Zecevic, 2008). Moreover, we iden-
tiﬁ  ed that this cell signaling involves the activation of the ERK1/2 
pathway and release of IL-6 from astrocytes. Notably, when astro-
cytes are stimulated with CXCL1, they secrete IL-6, which in turn 
acts on oligodendrocyte progenitors and induces their prolifera-
tion (Filipovic and Zecevic, 2008). Thus, we demonstrated that in 
contrast to rodents where CXCL1 directly induces oligodendrocyte 
proliferation (Robinson et al., 1998), in human fetal brain CXCL1 
has an indirect effect, acting through astrocyte secretion of IL-6, 
to increase oligodendrocyte proliferation.
At this point it became important to determine whether CXCL1 
promotes only proliferation or affects also differentiation of oli-
godendrocyte progenitors. To study this, we treated human fetal 
slices, isolated from midgestational VZ/SVZ, with CXCL1 (10 ng/
ml) for various lengths of time (12, 24, or 48 h). After treatment 
the number of MBP+ premyelinating oligodendrocytes was quan-
tiﬁ  ed in these brain slices. Although the number of MBP+ cells 
increased gradually, it was still not signiﬁ  cantly different than in 
control slices. However, when slices treated with CXCL1 (10 ng/
ml, 48 h), were cultured for additional 1 or 3 days, the number of 
MBP+ oligodendrocytes was signiﬁ  cantly higher than in controls 
slices, suggesting a delayed action of CXCL1 on differentiation 
of oligodendrocyte progenitors (Figure 9A). To better assess dif-
ferentiation of oligodendrocytes, we calculated a differentiation 
index, deﬁ  ned as the ratio between MBP+ cells and the sum of 
MBP+ and PDGFRα+ cells. A higher value of the differentiation Frontiers in Neuroanatomy  www.frontiersin.org  June 2009  | Volume 3  |  Article 5  |  10
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considering that the most important role of myelin sheath is to 
provide saltatory conduction of action potentials.
Myelination in the human brain progresses over several decades, 
which is much longer than a complete lifespan of the commonly 
studied animals. Recently emerged data suggest that myelination 
may play an important role in data processing by neurons (Fields, 
2008). On the one hand, it is now clear that human white mat-
ter changes with experience, i.e. that myelinating glia respond to 
environmental cues, as shown by magnetic resonance imaging of 
neglected children (Teicher et al., 2004). On the other hand, myelin 
thickness inﬂ  uences conduction velocity, which is in turn instru-
mental in regulation of synchronous ﬁ  ring of action potentials and 
proper function of the brain (Fields, 2008).
Finally, several myelin proteins, including Nogo-A, MAG and 
MOG cause the growth-cone collapse that prevents axons from 
reaching their targets (for review see Filbin, 2003). This feature of 
myelin is now appreciated as an important regulatory mechanism 
to suppress sprouting and formation of abnormal connections in 
development (Huang et al., 2005). It is thus essential to understand 
in disorders of the white matter during normal human brain 
development.
AXONAL SIGNALING AND MYELINATION IN THE HUMAN 
FETAL BRAIN
A wide variety of signals that may be involved in initiation of 
myelination of CNS axons has been reported. Although mouse 
oligodendrocytes in vitro have the capacity to form myelin-like 
membranes in the absence of neurons (Temple and Raff, 1986), 
co-culture with neurons signiﬁ  cantly increases MBP gene expres-
sion in these cultures (Macklin et al., 1986), suggesting that axons 
are necessary for efﬁ  cient myelination. In vivo experiments in the 
rat optic nerve demonstrated that oligodendrocyte proliferation 
and subsequent myelination depend on the electrical activity in 
axons (Barres and Raff, 1993). Other studies have conﬁ  rmed that 
ion channel activation or electrical activity in axons can regulate 
myelination (Demerens et al., 1996; Ishibashi et al., 2006; Stevens 
et al., 1998), suggesting that oligodendrocytes preferentially mye-
linate axons which ﬁ  re action potentials. This is not surprising, 
FIGURE 9 | Effect of CXCL1 on the differentiation of oligodendrocyte 
progenitors in slice cultures from VZ/SVZ region at midgestation. (A) Time-
dependent effect of CXCL1 on the number of MBP+ oligodendrocytes (OLs) per 
ﬁ  eld of view (FOV). OL number is signiﬁ  cantly different between control (CON) 
and CXCL1 treated slices after 5 div (n = 7 , *P < 0.05 vs. control slices) (B, C) The 
number of OLs in different experimental conditions after 120 h in vitro. 
(B) Decreased number of OLs is observed after inhibition of CXCR2 receptor or 
ERK1/2 pathway in CON and CXCL1 treated slices (n = 7 , *P < 0.05 vs. controls, 
#P < 0.05 vs. CXCL1 treated slices). (C) Treatment of slices with CXCL1 
stimulated astrocyte conditioned medium (CXCL1/ACM) signiﬁ  cantly increases 
the number of OLs, as compared to conditioned medium from unstimulated 
astrocytes (ACM). Reduced number of OLs cells is observed after ERK1/2 
inhibition, or after neutralization of IL -6, in ACM or in CXCL1-ACM. (n = 3, P < 0.05 
vs. ACM; #P < 0.05 vs. CXCL1–ACM). Error bars indicate SEM. (D–H) The 
morphology of MBP+ cells in the different conditions at 5div. (D) MBP+ 
oligodendrocytes in control slices. (E) OLs with multiple processes after CXCL1 
(10 ng/ml, 48 h) treatment. (F, G) OLs have fewer and shorter processes after 
CXCL1 treatment in a presence of CXCR2 antagonist (100 nM, 24 h) or PD98059 
(50 µM, 24 h), (H) Similar morphology is obtained when IL -6 is neutralized in 
CXCL1-ACM. (I) Western blot demonstrating upregulation of MBP (18.5 kD and 
17 kD isoforms) in CXCL1 (10 ng/ml, 48 h) treated cultures after 5div. Equal 
loading of proteins is conﬁ  rmed by actin. Scale bar: in (D) for (D–H), 20 µM.Frontiers in Neuroanatomy  www.frontiersin.org  June  2009 | Volume  3 | Article  5 | 11
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the Nogo-receptor interacting protein, LINGO-1, expressed by 
both axons and oligodendrocytes, negatively regulates myelina-
tion and its antagonist promoted spinal cord remyelination in the 
EAE model of MS (Mi et al., 2005, 2007).
Inhibitory signals in the brain act not only through cell-to-cell 
interactions, but also could travel through the cerebrospinal ﬂ  uid 
and the circulation, and thus are absent from the slice culture. 
Supporting this notion, although Nkx2.1- and Shh-deﬁ  cient mice 
lack mature oligodendrocytes, the cell cultures from these animals 
produce sufﬁ  cient numbers of pre-myelinating oligodendrocytes 
(Nery et al., 2001). This indicates that inhibitors present in vivo are 
lost when cells are grown in culture. The existence of possible inhib-
itors of myelination during normal development has great clinical 
importance, since the observed lack of functional remyelination in 
the MS plaques may be due to speciﬁ  c inhibition of oligodendrocyte 
differentiation, despite the fact that oligodendrocyte precursors 
are present in and around the lesions (Chang et al., 2002; Filipovic 
et al., 2002; Levine et al., 2001; Scolding et al., 1998).
OLIGODENDROCYTE DEVELOPMENT: RODENT VS. HUMAN
Since most studies of mammalian brain development are done on 
rodents, we ﬁ  nd it useful to understand how various time-points 
in rodent brain development correlate with much longer human 
brain development. In the literature there are just a few attempts 
to relate processes during rodent brain development with those 
in humans (Bayer et al., 1993; Clancy et al., 2007; Verley, 1977). 
Previous attempt to draw parallels between development of experi-
mental animals and humans resulted in designation of Carnegie 
stages (O’Rahilly, 1979). This classiﬁ  cation is based on somatic 
morphology of embryos and it presumes that brain develop-
ment is linearly predictable from somatic development, and that 
all brain regions develop at equivalent rates across species. Other 
attempts were done to make rat/primate comparisons based on 
neuroanatomy, comparing rat embryonic days 11–21 with human 
weeks 4–16 (Bayer et al., 1993). However, most of these compari-
sons do not take into account disparities in relative sizes of human 
brain regions. After a closer examination of our schematics of oli-
godendrocyte lineage markers expression during human develop-
ment given in Figure 2, it is clear that comparisons between human 
and rodent brains are neither easy to make, nor linear. Studies 
of human brain development from our laboratory suggest that 
processes like neurogenesis and oligodendrogliogenesis progress 
at different pace in the human brain, so every process has to be 
compared separately. Whereas neocortical neurogenesis does begin 
at 5 gw, corresponding to mouse embryonic day 10, the ending of 
neurogenesis is not that clear, since at the last time-point of our 
study, 24 gw neurons are still being born out of cells isolated from 
the cortical VZ/SVZ (Mo et al., 2007; 2008). Cortical oligoden-
drogenesis begins around 10 gw in humans, but it progresses well 
into adulthood in humans (Yakovlev and Lecourse, 1967). Based 
on the expression of markers of oligodendrocyte lineage, we will 
try to draw parallels between human and mouse development, 
focusing on the forebrain. PDGFRα mRNA in the mouse brain 
was ﬁ  rst detected at embryonic day 15 (E15), reached a peak at 
postnatal day 14 (P14), and fell to lower levels in adults (Yeh et al., 
1993). In contrast, mRNA for MBP was detected later, at P3–P4 in 
the mouse corpus callosum and the internal capsule, respectively 
cues and signals that oligodendrocytes need to initiate  unsheathing 
of axons in order to get insight into normal organization, and 
especially disorders of the human brain. Several uniquely human 
diseases, including multiple sclerosis and psychiatric disorders 
are linked to defects in myelination (Aston et al., 2005; Franklin, 
2002; Georgieva et al., 2006; Tkachev et al., 2003; Trapp and Nave, 
2008).
Before myelination is initiated, oligodendrocyte precursors 
transform ﬁ   rst to pre-myelinating oligodendrocytes and then 
into mature myelin-producing cells (Pfeiffer et al., 1993). During 
this process, myelin proteins, MBP and PLP, shift their expression 
from cell bodies to processes that form myelin sheaths (Hardy and 
Reynolds, 1991). In humans there is a clear dissociation between 
the time of oligodendrocyte differentiation and the beginning of 
myelination in the fetal forebrain (Back et al., 2001; Jakovcevski and 
Zecevic, 2005a). Pre-myelinating oligodendrocytes (O1+ cells) were 
present already at the beginning of midgestation (17–20 gw). The 
onset of myelination, however, was described only several months 
later, during the last trimester, ﬁ  rst in the basal ganglia and some-
what later in the corpus callosum (Back et al., 2001; Jakovcevski 
et al., 2007; Ulﬁ  g et al., 1998). Biochemical methods, such as detec-
tion of sulfatide by thin-layer chromatography and detection of 
MBP by SDS-PAGE, showed compact myelin in the human fore-
brain only after birth (Kinney et al., 1994).
We observed that the number of MBP+ oligodendrocytes dra-
matically increased in slice cultures of the human fetal forebrain, in 
comparison with their number in the frozen sections of the same 
fetal brains. Moreover, MBP+ cells in cultures appeared to be form-
ing myelin sheaths (Jakovcevski and Zecevic, 2005a; Jakovcevski 
et al., 2007). This may be attributed to the lack of inhibition of the 
oligodendrocyte differentiation in culture conditions and/or the 
presence of growth factors in the culturing medium. To explore 
the ﬁ  rst possibility, we demonstrated that a prominent increase 
in myelination coincided with the down-regulation of a polysialic 
acid conjugated form of the neural cell adhesion molecule (PSA-
NCAM). This ﬁ  nding is consistent with the notion that a PSA-
mediated signaling mechanism might be one of the regulators of 
primary myelination in the human fetal brain (Jakovcevski et al., 
2007). Notably, in multiple sclerosis patients, axons that fail to 
regenerate myelin sheathes, also re-express PSA-NCAM (Charles 
et al., 2002). There are, however, reports that in experimental CNS 
regeneration paradigms PSA promoted myelination (Mehanna 
et al., 2009; Papastefanaki et al., 2007). This indicates that a negative 
correlation between PSA-NCAM and myelination may be develop-
ment-speciﬁ  c, and dependent on the context in which myelina-
tion occurs.
It is important to stress that PSA-NCAM is not the only cell adhe-
sion molecule to be implicated as an axonal inhibitor of primary 
myelination. Many other molecules, for example neural adhesion 
molecule L1, have been shown to be downregulated from axonal 
surface upon the onset of myelination. Furthermore, interfering 
with L1 prior to myelination onset inhibited myelination (Barbin 
et al., 2004). This suggests that adhesion molecules are an important 
signal during initial contact between axon and oligodendrocyte, but 
their downregulation is needed for myelination to proceed. Other 
types of molecules that are inhibitory for myelination comprise 
oligodendrocyte myelin proteins and their receptors. For example Frontiers in Neuroanatomy  www.frontiersin.org  June 2009  | Volume 3  |  Article 5  |  12
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(Verity and Campagnoni, 1988). MBP expression reaches peak in 
the mouse cortical and   subcortical white matter at P20, when pri-
mary myelination is completed (Campagnoni and Macklin, 1988; 
Verity and Campagnoni, 1988). In the human forebrain, the ﬁ  rst 
early oligodendrocyte progenitors appear at 10 gw, which then 
can be compared to E15 in mice. The ﬁ  rst MBP+ premyelinating 
oligodendrocytes are detected at 18 gw in humans, which then is 
comparable to P3 mouse (Figure 2). Our observations on early 
oligodendrocyte development and myelination onset, however, 
roughly ﬁ  t into the previously proposed model of human-to-rodent 
development comparison (Bayer et al., 1993). Subsequently human 
primary forebrain myelination takes decades, compared to weeks in 
rodents (Yakovlev and Lecourse, 1967). The most important reason 
for this prolonged development is that much larger human brain 
has entire neocortical regions which rodent brains completely lack, 
whereas some of the key regions of rodent brains are in human 
relatively underdeveloped (e.g. olfactory bulbs).
Another interesting issue is concerning the overall number of 
oligodendrocytes in human versus rodent brain. Although numbers 
of oligodendrocytes needed to myelinate large human brains are 
much higher than in rodents, it is not as clear if the densities and 
proportions of oligodendrocytes are different. In mouse cerebral 
and cerebellar cortex, for example, the density of oligodendrocytes 
was estimated to be 12.5 × 103/mm3, which makes for approximately 
5% of all cells detected by the nuclear staining (Irintchev et al., 2005; 
Jakovcevski et al., 2009). Comparable stereological studies of the 
human prefrontal cortex suggest very similar densities for oligoden-
droglia in humans (Ongur et al., 1998; Stark et al., 2004). These 
studies also demonstrated decreased density of oligodendrocytes 
in patients with schizophrenia and mood disorders (Ongur et al., 
1998; Stark et al., 2004).
In conclusion, greater complexity of the human brain, includ-
ing its longer development, larger size, and the existence of unique 
regions and functions, as well as uniquely human pathologies calls 
for more studies on human brain development. The fact that many 
more oligodendrocytes need to be generated to myelinate a huge 
amount of axons in the large white matter of the human brain, 
supports the idea that oligodendrocytes may be generated for a 
longer time period and also from various progenitor sources than in 
the far smaller rodent brain. Inter-species differences, thus, should 
be taken into consideration when extrapolating results from ani-
mal models to primate and particularly human brain. The main 
difﬁ  culty in conducting studies on human brain development is 
the limited source of human brain tissue, but hopefully this will 
change with more groups working in the ﬁ  eld of human develop-
ment enabling easier comparisons of results (e.g. Bayatti et al., 2008; 
Fertuzinhos et al., 2009; Petanjek et al., 2008; Stillman et al., 2009). 
Another promising new direction is the use of human embryonic 
stem cells-derived tissues that would allow in vitro studies of devel-
opmental processes on a much larger scale and in a more repro-
ducible manner.
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